Centre for Neuroscience and Cell Biology & Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal.
Pharm Res. 2010 Feb;27(2):211-23. doi: 10.1007/s11095-009-0011-3. Epub 2009 Dec 1.
It has long been known that protection against pathogens invading the organism via mucosal surfaces correlates better with the presence of specific antibodies in local secretions than with serum antibodies. The most effective way to induce mucosal immunity is to administer antigens directly to the mucosal surface. The development of vaccines for mucosal application requires antigen delivery systems and immunopotentiators that efficiently facilitate the presentation of the antigen to the mucosal immune system. This review provides an overview of the events within mucosal tissues that lead to protective mucosal immune responses. The understanding of those biological mechanisms, together with knowledge of the technology of vaccines and adjuvants, provides guidance on important technical aspects of mucosal vaccine design. Not being exhaustive, this review also provides information related to modern adjuvants, including polymeric delivery systems and immunopotentiators.
长期以来,人们已经知道,与血清抗体相比,针对通过黏膜表面入侵机体的病原体的保护作用与局部分泌物中特定抗体的存在相关性更好。诱导黏膜免疫的最有效方法是将抗原直接施用于黏膜表面。黏膜应用疫苗的开发需要抗原递送系统和免疫增强剂,这些系统和增强剂能够有效地促进抗原向黏膜免疫系统的呈递。本文综述了导致保护性黏膜免疫应答的黏膜组织内的事件。对这些生物学机制的理解,以及对疫苗和佐剂技术的了解,为黏膜疫苗设计的重要技术方面提供了指导。由于篇幅限制,本文还提供了与现代佐剂(包括聚合物递送系统和免疫增强剂)相关的信息。